Zacks.com on MSN
Globus Medical (GMED) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Globus Medical (GMED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Fintel reports that on October 28, 2025, Stifel reiterated coverage of Globus Medical (NYSE:GMED) with a Hold recommendation.
Globus Medical stock is currently trading approximately 33% below its 1-year high and is also trading at a PS multiple that ...
But the Swiss Alps, synonymous known for their snowy slopes, skiers and snowboarders, are the setting for the so-called “coldest cricket tournament on Earth”. First, let’s wind the clock back to ...
TPG's Gene Sloan offers a glimpse at what a Globus tour is like after a seven-day trip to Scotland with the brand.
Globus Medical's consensus analyst price target has seen a modest decline, moving from $80.30 to $78.18, following a slight uptick in the discount rate. These adjustments reflect a shifting narrative ...
Globus includes airport pickups on air-inclusive trips to remove this potential pain point. A Globus representative will meet ...
A new report by Funnelsaudit.ai and UK-based digital performance research company, ConversionTracker.com ranks Globus Bank as Nigeria’s top performer in ...
Globus Bank hosted the Fintech Summit 2025 in Lagos, promoting collaboration between banks and fintechs as the key to accelerating ...
The radiation oncology company said before the opening bell Monday that Suzanne Winter is retiring as CEO and has been succeeded by Steve La Neve, a former executive of Globus Medical. Winter will ...
Globus Medical launched the Anthem Elbow Fracture System, a plating system designed to help surgeons manage a wide range of elbow fractures with simplified workflow and flexible fixation options.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results